Coronavirus Update: BioNTech And Fosun Launch Vaccine Trial In China
And UK Government Teams Up With Wockhardt
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.
